DHT.UN is a healthcare royalty investment company. Yield is 2.79% and valuation is quite low on a P/E basis. Market cap is $800M after a 13% gain already in 2024. High revenue growth is expected this year, but more muted EPS growth ($1.39 to $1.41). POW owns 20% of the company. We like its royalty portfolio, and last week the company upped its guidance in terms of expected capital deployment, to $1.25B over five years. This should (assuming good deals) set up good long term future cash flow. It is an interesting name in the (generally weak) Canadian healthcare space. It offers both income and growth potential, and should have some degree of stability. It is still a management bet on their ability to structure good deals, but so far, so good, in that regard.
5i Research Answer: